Optimal therapy of advanced Hodgkin lymphoma.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2011, Issue , 2011, Pages 310-316

  Advani, Ranjana ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER STAGING; HODGKIN DISEASE; HUMAN; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR;

ANTINEOPLASTIC AGENTS; HODGKIN DISEASE; HUMANS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84859403395     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2011.1.310     Document Type: Review

References (0)